We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
The FDA has allowed 23andMe to market a new direct-to-consumer genetic test that provides information about how a person metabolizes some medications. The test, approved to detect 33 ...
Privacy issues in the use of such DNA testing kits came to the forefront with the arrest of Golden State Killer, when it was revealed that police had used data from GEDMatch.
23andMe made two announcements on the same day that point towards the future of its business: it revealed it had raised $250 million in financing and released details from a long-running study into Parkinson’s disease.